(0.08%) 5 252.59 points
(0.05%) 39 779 points
(-0.05%) 16 391 points
(1.67%) $82.71
(0.58%) $1.728
(1.07%) $2 236.30
(0.74%) $24.94
(1.38%) $922.25
(0.26%) $0.926
(0.64%) $10.84
(-0.01%) $0.791
(0.10%) $92.53
Live Chart Being Loaded With Signals
Context Therapeutics Inc., a clinical-stage biopharmaceutical company, develops products for the treatment of cancer for women in the United States. Its lead product candidate is onapristone extended release (ONA-XR), a potent and selective antagonist of the progesterone receptor that is linked to resistance for various classes of cancer therapeutics, such as anti-estrogen therapies across female hormone-dependent cancers...
Stats | |
---|---|
Today's Volume | 32 039.00 |
Average Volume | 46 565.00 |
Market Cap | 22.99M |
EPS | $0 ( 2024-03-27 ) |
Next earnings date | ( $-0.390 ) 2024-05-08 |
Last Dividend | $0 ( N/A ) |
Next Dividend | $0 ( N/A ) |
P/E | -0.960 |
ATR14 | $0.0210 (1.46%) |
Date | Person | Action | Amount | type |
---|---|---|---|---|
2024-03-21 | Minai-azary Jennifer Lynn | Buy | 160 115 | Stock Option (right to buy) |
2024-03-21 | Levit Alex C. | Buy | 153 515 | Stock Option (right to buy) |
2024-03-21 | Lehr Martin A. | Buy | 291 402 | Stock Option (right to buy) |
2023-05-31 | Kantoff Philip W. | Buy | 25 000 | Stock Option (right to buy) |
2023-05-31 | West Linda | Buy | 25 000 | Stock Option (right to buy) |
INSIDER POWER |
---|
100.00 |
Last 72 transactions |
Buy: 4 162 098 | Sell: 2 098 089 |
Volume Correlation
Context Therapeutics Inc. Correlation
10 Most Positive Correlations | |
---|---|
SGH | 0.957 |
KOPN | 0.957 |
PLAB | 0.949 |
ALR | 0.941 |
STER | 0.939 |
ELTK | 0.938 |
MRVL | 0.935 |
XBIT | 0.931 |
EVLO | 0.927 |
CALA | 0.927 |
10 Most Negative Correlations | |
---|---|
OPTN | -0.919 |
SBNYP | -0.909 |
ASO | -0.901 |
FANH | -0.899 |
ATHN | -0.896 |
PHCF | -0.895 |
CDAK | -0.885 |
PAYS | -0.885 |
MTSI | -0.877 |
AGFS | -0.876 |
Did You Know?
Correlation is a statistical measure that describes the relationship between two variables. It ranges from -1 to 1, where -1 indicates a perfect negative correlation (as one variable increases, the other decreases), 1 indicates a perfect positive correlation (as one variable increases, the other increases), and 0 indicates no correlation (there is no relationship between the variables).
Correlation can be used to analyze the relationship between any two variables, not just stocks. It's commonly used in fields such as finance, economics, psychology, and more.
Context Therapeutics Inc. Correlation - Currency/Commodity
Context Therapeutics Inc. Financials
Annual | 2023 |
Revenue: | $0 |
Gross Profit: | $-12 044.00 (0.00 %) |
EPS: | $-1.500 |
Q4 | 2023 |
Revenue: | $0 |
Gross Profit: | $-2 568.00 (0.00 %) |
EPS: | $-0.420 |
Q3 | 2023 |
Revenue: | $0 |
Gross Profit: | $-3 089.00 (0.00 %) |
EPS: | $-0.370 |
Q2 | 2023 |
Revenue: | $0 |
Gross Profit: | $-3 194.00 (0.00 %) |
EPS: | $-0.310 |
Financial Reports:
No articles found.
Context Therapeutics Inc.
Context Therapeutics Inc., a clinical-stage biopharmaceutical company, develops products for the treatment of cancer for women in the United States. Its lead product candidate is onapristone extended release (ONA-XR), a potent and selective antagonist of the progesterone receptor that is linked to resistance for various classes of cancer therapeutics, such as anti-estrogen therapies across female hormone-dependent cancers. The company is also developing CLDN6xCD3 bsAb, an anti-CD3 x anti-Claudin 6 antigen bispecific monoclonal antibody that is intended to redirect T-cell-mediated lysis toward malignant cells expressing CLDN6. The company has a collaboration and licensing agreement with Integral Molecular, Inc. for the development of an anti-claudin 6 bispecific monoclonal antibody for gynaecologic cancer therapy. Context Therapeutics Inc. was incorporated in 2015 and is headquartered in Philadelphia, Pennsylvania.
About Live Signals
The live signals presented on this page help determine when to BUY or SELL NA. The signals have upwards of a 1-minute delay; like all market signals, there is a chance for error or mistakes.
The live trading signals are not definite, and getagraph.com hold no responsibility for any action taken upon these signals, as described in the Terms of Use. The signals are based on a wide range of technical analysis indicators